Anti-Testosterone Study Is Misleading, Overhyped: Top Doctor

Chemical Structure of Testosterone.
Chemical Structure of Testosterone. (Photo credit: Wikipedia)
A new headline-making study warning of dire side effects from testosterone medications is misleading and has been overhyped, says a top hormone therapy expert.
 
“I’m concerned that men will stop taking testosterone because of this new study,” Erika Schwartz, M.D., told Newsmax Health. “It contradicts all the previous research that shows the benefits of this form of therapy. When taken properly, the results of testosterone therapy can be amazing.”
 
Editor's Note: Video Exposes Dangers of Obamacare Law

The new research suggests that men who take testosterone after undergoing a minor cardiac procedure are more likely to suffer strokes, heart attacks, or die. The study was published in the Journal of the American Medical Association. The  findings directly contradict a similar study done last year, which found that similarly aged men who took testosterone had a 50 percent less risk of dying, noted Dr. Schwartz, a leading national expert who has hosted a PBS special on hormone therapies.
 
The major difference between the two studies was the condition of the subjects. Most of the men in the new study had serious health problems, including a prior history of heart attack, congestive heart failure, or confirmed coronary heart disease. Men in the previous study were healthier.
 
“All this study showed was that older men with heart disease, who are sick, are not likely to benefit from starting testosterone therapy. It says nothing about the relatively healthy men who have benefited from testosterone therapy and use it for prevention,” said Dr. Schwartz. “My patients, if they start testosterone early enough, they benefit tremendously.”
 

Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Headline/testosterone-low-t-aging-dangers/2013/11/07/id/535445#ixzz2k3jjP5a8
Alert: What Is Your Risk for a Heart Attack? Find Out Now
Enhanced by Zemanta

No comments: